Target intelligence / Profile preview

General Lipid Metabolism Pathways

Molecular classification
Other
01

Overview

General lipid metabolism pathways refer to the integrated network of biochemical reactions responsible for the synthesis, transport, and degradation of lipids, including fatty acids, triglycerides, and cholesterol (StatPearls, 2023). These pathways are fundamental for energy storage, the formation of cellular membranes, and the production of signaling molecules like steroid hormones (NIH, 2019). While the term itself describes a broad biological process rather than a single molecular target, it encompasses numerous specific enzymes, receptors, and transporters that serve as critical therapeutic targets. Dysregulation of lipid metabolism is a hallmark of metabolic syndrome and is strongly associated with the development of atherosclerosis, cardiovascular disease, and nonalcoholic fatty liver disease (PubMed, 2021). Pharmacological agents often target specific nodes within these pathways, such as HMG-CoA reductase for cholesterol lowering or PPAR receptors for triglyceride management (Mayo Clinic, 2023). Consequently, monitoring lipid profiles remains a cornerstone of clinical practice for assessing metabolic health and drug efficacy.

Other names
Lipid metabolismFatty acid metabolismCholesterol metabolismLipogenesisLipolysisLipid homeostasis
02

Mechanism of action

Drugs targeting components of these pathways act through various mechanisms, including the inhibition of rate-limiting enzymes like HMG-CoA reductase, activation of nuclear receptors such as PPAR-alpha, or the inhibition of intestinal cholesterol absorption and proprotein convertase subtilisin/kexin type 9 (PCSK9).

03

Biological functions

MetabolismEnergy storageCell signalingMembrane structural integrityHormone synthesis
04

Disease associations

Cardiovascular diseaseDyslipidemiaObesityDiabetes mellitusNonalcoholic fatty liver diseaseAtherosclerosis
05

Safety considerations

MyopathyRhabdomyolysisHepatotoxicityGastrointestinal distressIncreased risk of new-onset diabetesElevated liver transaminases
06

Interacting drugs

Atorvastatin

6 more in the full profile.

07

Biomarkers

Low-density lipoprotein cholesterol (LDL-C)High-density lipoprotein cholesterol (HDL-C)TriglyceridesApolipoprotein BTotal cholesterolLipoprotein(a)

Beyond the preview

Go deeper on General Lipid Metabolism Pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on General Lipid Metabolism Pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call